These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23233080)

  • 1. Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.
    Thoonen R; Sips PY; Bloch KD; Buys ES
    Curr Hypertens Rep; 2013 Feb; 15(1):47-58. PubMed ID: 23233080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
    Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
    Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO-cGMP signaling and regenerative medicine involving stem cells.
    Madhusoodanan KS; Murad F
    Neurochem Res; 2007; 32(4-5):681-94. PubMed ID: 17043768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitric oxide/cGMP signaling pathway in pulmonary hypertension.
    Klinger JR
    Clin Chest Med; 2007 Mar; 28(1):143-67, ix. PubMed ID: 17338933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing.
    Schmidtko A; Tegeder I; Geisslinger G
    Trends Neurosci; 2009 Jun; 32(6):339-46. PubMed ID: 19414201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism.
    Chamorro-Jorganes A; Grande MT; Herranz B; Jerkic M; Griera M; Gonzalez-Nuñez M; Santos E; Rodriguez-Puyol D; Lopez-Novoa JM; Rodriguez-Puyol M
    Hypertension; 2010 Sep; 56(3):484-9. PubMed ID: 20679183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase.
    Birschmann I; Walter U
    Acta Biochim Pol; 2004; 51(2):397-404. PubMed ID: 15218537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
    Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
    Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.
    Patel D; Lakhkar A; Wolin MS
    Adv Exp Med Biol; 2017; 967():227-240. PubMed ID: 29047089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration.
    Aggarwal S; Gross CM; Kumar S; Datar S; Oishi P; Kalkan G; Schreiber C; Fratz S; Fineman JR; Black SM
    J Cell Physiol; 2011 Dec; 226(12):3104-13. PubMed ID: 21351102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting.
    Ruth P
    Pharmacol Ther; 1999; 82(2-3):355-72. PubMed ID: 10454212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide/cyclic GMP relaxing pathway in the human umbilical vein.
    Beaumann M; Delhaes F; Menétrey S; Joye S; Vial Y; Baud D; Magaly JG; Tolsa JF; Peyter AC
    Placenta; 2020 Apr; 93():83-93. PubMed ID: 32250743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.
    Cohen RA; Vanhoutte PM
    Circulation; 1995 Dec; 92(11):3337-49. PubMed ID: 7586323
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitric Oxide Signaling Pathway and Vascular Activity].
    Gao YS
    Sheng Li Ke Xue Jin Zhan; 2017 Feb; 48(1):58-62. PubMed ID: 29927223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease.
    Dao VT; Elbatreek MH; Deile M; Nedvetsky PI; Güldner A; Ibarra-Alvarado C; Gödecke A; Schmidt HHHW
    Sci Rep; 2020 Jun; 10(1):10012. PubMed ID: 32561822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology.
    Adachi T
    Adv Pharmacol; 2010; 59():165-95. PubMed ID: 20933202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.